Blue Crest Capital Management LTD Vbi Vaccines Inc Transaction History

Blue Crest Capital Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.22 - $2.41 $63,221 - $124,888	-51,821 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.75 - $2.93 $262,540 - $439,567	-150,023 Reduced 74.33%	51,821 $125,000
Q2 2018 Aug 14, 2018	BUY	$2.75 - $3.85 $555,071 - $777,099	201,844 New	201,844 $555,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.